M
acrophages are among the frontline defenders against invading organisms (1) . However, they can also act as cellular hosts for intracellular pathogens, including Mycobacterium tuberculosis, the causative agent of tuberculosis (2) . The lymphocyte secreted cytokine IFN-g is the predominant activator of macrophage microbicidal activity, turning on a transcriptional program for the killing of intracellular pathogens through JAK-STAT signaling downstream of the type II IFNR (3) . Phosphorylation of STAT1 and formation of homodimers upon type II IFNR engagement results in translocation to the nucleus where the STAT1 homodimers engage with transcriptional coactivators, including the coactivator p300, to initiate transcription of IFN-g-induced genes (4). p300 interacts with a variety of transcription factors and has been identified as an important transcriptional mediator of immune defenses, including IFN-g response genes, against many intracellular pathogens (5-9).
IFN-g activity is essential for control of M. tuberculosis in murine models (10) ; however, the effects of IFN-g are not as clear in humans. Although lack of IFN-g signaling predisposes individuals to infections with intracellular pathogens, including several mycobacteria species (11) (12) (13) , high levels of IFN-g have been detected in the pleural fluid of TB patients (14) , and IFN-g therapy for tuberculosis in humans has not demonstrated the same striking results as in murine models (15) . These observations can be accounted for by the discovery that M. tuberculosis blocks IFN-g signaling and subsequent activation of human macrophage functions by interrupting the p300 association with STAT1 homodimers within the nucleus, causing reduced binding at the g-activation sequences of IFN-g response genes (9) .
MicroRNAs (miRNAs) are endogenous, noncoding, small RNAs that function as gene regulators, most commonly by mediating translational repression or degradation of target mRNAs, which can have widespread effects on downstream pathways (16) . Manipulation of host miRNA expression may be another mechanism by which M. tuberculosis is able to subvert immune detection and persist intracellularly within macrophages. Recent discoveries from our laboratory demonstrate that virulent M. tuberculosis can modify the human macrophage immune response by modulating miR-125b expression, which, in turn, decreases levels of TNF-a, another major cytokine for M. tuberculosis control (17) . In this study, we sought to identify additional miRNAs whose expression is altered during M. tuberculosis infection of primary human macrophages and elucidate the functions of some of these miRNAs. We provide evidence that M. tuberculosis induces host miRNAs miR-132 and miR-26a. Induction of these miRNAs reduces p300 expression, thereby diminishing transcription of IFN-g-induced genes and macrophage responsiveness to this key lymphokine.
Materials and Methods

Reagents and buffers
Dulbecco's PBS without Ca 2+ and Mg 2+ , RPMI medium 1640 with L-glutamine, DMEM medium, HEPES buffer, and TRIzol were purchased from Invitrogen. 7H11 agar plates were prepared with Bacto Middlebrook 7H11 from Difco Laboratories, oleic acid-albumin-dextrose-catalase enrichment medium, and glycerol. Human serum albumin was purchased from CSL Behring, and recombinant human IFN-g was obtained from R&D Systems.
Bacterial strains and preparation for infection
Lyophilized Mycobacterium tuberculosis H 37 R v (ATCC #25618) was obtained from the American Tissue Culture Collection, reconstituted, and used as described previously (18) . The concentration of bacteria and the degree of clumping (#10%) were determined by Petroff-Hausser chamber counting; bacteria prepared in this fashion are $90% viable by CFU assay. For paraformaldehyde-killed M. tuberculosis, the single-cell suspension was pelleted and resuspended in 4% paraformaldehyde for 10 min, washed once in PBS, and resuspended in RPMI 1640 medium with 10 mM HEPES and 0.4% human serum albumin for Petroff-Hausser counting.
Isolation of human monocyte-derived macrophages and cell culture of monocyte-derived macrophages and HEK293 cells
To obtain monocyte-derived macrophages (MDMs), we obtained blood from healthy, purified protein derivative-negative human volunteers using a protocol approved by The Ohio State University Institutional Review Board and processed as described previously (19, 20 
M. tuberculosis infection of human macrophages
Six-or 12-d-old MDMs were incubated with M. tuberculosis at a multiplicity of infection of 5:1 in RPMI 1640 medium with 10 mM HEPES and 0.4% human serum albumin for 30 min at 37˚C in 5% CO 2 on a platform shaker for equal dispersion of bacteria followed by an additional 90-min incubation without shaking. MDMs were washed three times with warm RPMI 1640 and repleted with RPMI 1640 containing 2% autologous human serum for the remainder of the experiment.
NanoString nCounter miRNA expression profiling
The digital multiplexed NanoString nCounter miRNA assay (NanoString Technologies) was used for miRNA expression profiling of 24-and 72-h M. tuberculosis-infected MDMs (n = 4 individual donors). A total of 100 ng high-quality total RNA, including small RNAs, isolated by phenolchloroform extraction was used as input material. Small RNAs were prepared for detection by ligating a specific DNA tag (miR-tag) onto the 39 end of each mature miRNA with the aid of a bridge oligomer according to the manufacturer's instructions. miR-tags serve not only to normalize the wide range of miRNA melting temperatures, but also aid in identification between homologous miRNA family members, enabling single-bp discrimination. Excess tags were removed by restriction digestion, and the resulting material was hybridized with miRNA:tag-specific nCounter Capture and barcoded Reporter probes. Hybridization reactions were incubated at 64˚C for 18 h according to the manufacturer's instructions before removal of excess probes by a magnetic bead-based purification process; purified hybridized probe complexes were immobilized on a streptavidin-coated cartridge using the nCounter Prep Station. The nCounter Digital Analyzer was used to count individual fluorescent barcodes and quantify target miRNA molecules present in each sample. For each assay, a high-density scan (600 fields of view) was performed. Data normalization and analysis were performed by the Ohio State University Bioinformatics Core Facility according to the manufacturer's guidelines.
NanoString data analysis
Specific background correction factors were applied to certain miRNAs according to the manufacturer's directions to account for nonhybridizationdependent interactions of some bridge oligomers, miR-tags, or capture and reporter probes. Technical normalization of the code counts was performed using spiked mRNA + controls according to the manufacturer's instructions, and background was determined by the included negative controls. Each sample was then normalized to the geometric mean of the top 50 most highly expressed miRNAs. miRNAs with normalized counts ,50 (average background count) in all groups were removed, and Student t test was used to calculate the statistical significances of pairwise comparisons of the remaining miRNAs with a cutoff of p , 0.05 considered significant. Calculations were performed using the R statistical computing environment.
Transfection
PBMCs were transfected with 100 nM each of mirVana miR-132 and miR26a inhibitors or mimics, together with the appropriate negative controls (Applied Biosystems) by the Amaxa Nucleofector (Lonza Group) as described previously (21, 22) . In brief, 5-d-old PBMCs (1 3 10 7 ) were resuspended in 100 ml nucleofector solution, followed by the addition of siRNA or control, incubated at room temperature for 5 min, and nucleofected according to the manufacturer's instructions. Plasmids and miRNA mimics were cotransfected into HEK293 cells using Lipofectamine 2000 (Invitrogen) according to manufacturer's instructions.
Untranslated region cloning and luciferase reporter assay
A fragment of the human p300 39 untranslated region (UTR) containing binding sites for miR-132 and miR-26a was amplified using the primers 59-GCTCTAGATTTCTCTGGGTGCAAAGATG-39 and 59-GCTCTAGA-TGTCTGTCTCACACAGTTTATT-39. The amplified product was subcloned into the XbaI site downstream of the luciferase gene on the pGL3_CMV vector (a modified form of Promega's pGL3). The miR-132 and miR-26a binding sites in the 39UTR of p300 were mutated using the Q5 Site-Directed Mutagenesis kit (New England BioLabs) using primers 59-CACTGTATAGGAGTTTAAATTTGATTTCTTATTACCTATTGTTA-AATAAAC-39 and 59-ATCCAAAGTTCATATTTATAAGTAATC-39 for miR-132 and 59-TTTCTATAAAGACCGAAAATAGCAAAAACCCTCA-ACTG-39 and 59-GTGTGTGTGTGTGTGTGTG-39 for miR-26a. Sequencing was performed to verify the correct alignment of all constructs. For luciferase reporter assays, HEK293 cells were cotransfected with 5 ng p300 39UTR constructs and 100 nM control miRNA or miR-132 and/or miR-26a mimics (Applied Biosystems) by Lipofectamine 2000. Forty-eight hours after transfection, luciferase activity was measured using the Promega Luciferase Assay System according to the manufacturer's protocol.
miRNA and gene expression studies by quantitative real-time RT-PCR MDM monolayers were treated with 40 ng/ml recombinant human IFN-g for varying times. M. tuberculosis-infected or IFN-g-stimulated MDMs in triplicate wells were lysed in TRIzol reagent, and total RNA (including small RNA) was isolated according to manufacturer's instructions. RNA quantity and quality were evaluated by NanoDrop 2000 spectrophotometer. Total RNA (100 ng) was reversed transcribed to cDNA by SuperScript II reverse transcriptase (Invitrogen), and expression of CD64, CYBB, IRF1, HLA-DRa, CXCL10, and CD86 were determined by quantitative real-time RT-PCR (qRT-PCR) using TaqMan Gene Expression Assays (Applied Biosystems) and normalized to b-actin as a housekeeping gene. miR-132 and miR-26a cDNA were generated from RNA using the TaqMan MicroRNA Reverse Transcription kit (Applied Biosystems). Expression of miR-132 and miR-26a was determined by qRT-PCR using TaqMan MicroRNA Assays with RNU44 as housekeeping control (Applied Biosystems). Negative controls in all qRT-PCRs included no reverse transcriptase and no template (cDNA) groups in the reactions. Triplicate samples were analyzed in duplicate wells in each experiment.
Western blotting
MDM monolayers were washed once in PBS and lysed in TN-1 lysis buffer (50 mM Tris, 10 mM EDTA, 10 mM Na 4 PO 7 , 10 mM NaF, 1% Triton X-100, 125 mM NaCl, 10 mM Na 3 VO 4 , 10 mg/ml each aprotinin and leupeptin) at 4˚C for 10 min and centrifuged at 10,000 3 g for 10 min at 4˚C to remove cell debris (23) . Protein concentrations of the cleared lysates were measured by the BCA protein assay kit (Pierce). Protein-matched total cell lysates were separated by SDS-PAGE and analyzed by Western blot using the following Abs: p300 and b-actin (Santa Cruz), STAT1, JAK1, and JAK2 (Cell Signaling), HLA-DR (clone L243; BD Biosciences), and CD64 (clone 22.2), generously provided by Dr. Clark Anderson (The Ohio State University). The protein band intensities were measured using the online ImageJ software provided by the National Institutes of Health. Background intensity was subtracted from each sample and then normalized to the b-actin loading control.
Confocal microscopy
Transfected MDMs were adhered to glass coverslips in 24-well tissue culture plates for 2-3 h at 37˚C and washed to remove lymphocytes. MDMs were treated with IFN-g for 48 h, washed, and fixed in 2% paraformaldehyde, then blocked in blocking reagent (5% BSA, 10% FBS in PBS). Coverslips were incubated with primary Ab or the appropriate isotype control for 1 h at room temperature, washed with blocking reagent, and counterstained with an Alexa Fluor-conjugated secondary Ab (Molecular Probes) for 1 h at room temperature. Nuclei were labeled with the DNA stain DAPI (Molecular Probes). Finally, coverslips were washed and mounted on glass slides and viewed using an Olympus Fluoview confocal microscope.
Phagocytosis assay
IgG-coated SRBCs were prepared as described previously (24) and then incubated with transfected MDMs on coverslips at a ratio of 50:1 for 1 h in RPMI 1640 at 37˚C. Cells were subjected to brief hypotonic lysis for removal of extracellularly bound SRBCs and fixed in paraformaldehyde. Phagocytosis through the FcgRs was confirmed by the lack of ingested SRBCs by MDMs incubated with SRBCs not opsonized with IgG (data not shown). Phagocytosis was measured by the total number of ingested SRBCs in 100 MDMs (phagocytic index).
Statistical analysis
Most experiments were performed at least three independent times using three different donors and yielded similar results. The magnitude of the response from each independent experiment varied among the donors; however, the pattern of experimental results was the same from donor to donor. To account for this variability, we normalized the data to an internal control in each experiment. A ratio of experimental results to control was obtained, and the mean ratio was then tested for a significant difference from one using t statistics. An unpaired one-tailed Student t test was used to analyze differences between groups. A p value , 0.05 was considered significant.
Results
Identification of macrophage miRNAs altered during M. tuberculosis infection
To identify the human macrophage miRNAs whose expression is altered during M. tuberculosis infection, we performed global miRNA expression profiling in primary human MDMs postinfection with the virulent standardized strain M. tuberculosis H 37 R v by the NanoString nCounter miRNA Expression Assay. MDM miRNAs at 24 (Fig. 1A) and 72 h (Fig. 1B) after M. tuberculosis infection were compared with miRNAs from the noninfected control. The times of 24 and 72 h postinfection were chosen to reflect the phases of entry and acclimatization to the intracellular environment (24 h) and initial rounds of intracellular replication (72 h). To identify statistically significant candidate miRNAs regulated by M. tuberculosis infection, we first generated a subset of miRNAs expressed in MDMs ($50 copies detected in at least one group and consistent in all donors tested) and then used a cutoff of p , 0.05 when compared with the noninfected control.
Cumulative results from four donors indicated that at 24 h, three miRNAs, miR-490-3p, let-7i, and miR-29a, were significantly upregulated, whereas three additional miRNAs, miR-361-5p, miR23b, and miR-221, were significantly downregulated relative to the noninfected control (Fig. 1C) . At 72 h postinfection, we identified 10 significantly upregulated miRNAs: miR-132, miR-146b-5p, miR-30e, let-7i, miR-490-3p, miR-29c, miR-26a, miR-21, let7b, and miR-29a. In addition, 21 miRNAs were significantly downregulated at 72 h postinfection relative to the noninfected control: miR-25, miR-23b, miR-331-3p, miR-423-3p, miR-548f, miR-340, miR-24, miR-107, miR-93, miR-324-5p, miR-188-5p, miR-130b, miR-410, miR-361-5p, miR-197, miR-27a, miR-128, miR-345, miR-379, miR-133a, and miR-221 (Fig. 1D) . Of note, all six of the significantly altered miRNAs at 24 h postinfection were also significantly altered with the same patterns at 72 h postinfection. Therefore, we focused our efforts on further characterization of miRNA functions on the regulated miRNAs at 72 h post M. tuberculosis infection.
Validation of miRNA expression patterns by qRT-PCR
To validate the miRNA expression profiling results, we used qRT-PCR to assay expression of several upregulated and downregulated miRNAs including miR-132 (the most upregulated miRNA at 72 h postinfection; Fig. 2A, 2B ) and miR-26a (Fig. 2C, 2D) , and additional miRNAs of interest: let-7i, miR-221 (the most downregulated miRNA at 72 h postinfection), and miR-128 (Supplemental Fig. 1 ). When compared with the expression profiles as established by NanoString, the qRT-PCR validation results demonstrate great congruence between the expression patterns determined using these two techniques for these miRNAs. Although we cannot conclude that the patterns of alteration for these miRNAs are specific responses to M. tuberculosis, our results confirm that miR-132, miR-26a, let-7i, miR-221, and miR-128 are distinctly regulated in human macrophages after M. tuberculosis infection.
Paraformaldehyde-killed M. tuberculosis also induces miR-132 and miR-26a upregulation Because the observation of increased miR-132 and miR-26a expression was observed at 72 h after M. tuberculosis infection, which is the time at which M. tuberculosis is undergoing early rounds of replication in our model, we investigated whether induction of miR-132 and miR-26a expression requires replicating M. tuberculosis. We stimulated MDMs with paraformaldehyde- 
and cannot secrete mycobacterial products, but it possesses an intact cell-wall structure (25) . The results in Fig. 2E and 2F show that treatment of MDMs with paraformaldehyde-killed M. tuberculosis also induced miR-132 and miR-26a expression at 72 h, indicating that replication is not required for the effect observed
Identification of transcriptional coactivator p300 as a target of M. tuberculosis upregulated miR-132 and miR-26a
We selected miR-132 for further analysis because it was the most upregulated miRNA at 72 h postinfection and its expression pattern FIGURE 3. p300 is a target of miR-132 and miR-26a in human macrophages. Knockdown (A and B) or overexpression (C and D) of miR-132 and miR26a was achieved by transfection of specific inhibitors or mimics and confirmed by qRT-PCR. p300 protein levels were analyzed by Western blot of proteinmatched total cell lysates from (E) double miRNA knockdown or (F) double miRNA overexpressing MDMs (left panels). Blots were probed with actin as a loading control. Densitometry analysis of the immunoblot results show an increase in p300 levels with miR-132 and miR-26a knockdown, whereas p300 protein levels decreased with miR-132 and miR-26a overexpression (right panels). Shown are representative Western blots and cumulative densitometry data representing data from five individual experiments for the knockdown and six individual experiments for the overexpressor groups (mean 6 SEM, *p , 0.05, **p , 0.01, ***p , 0.001).
The Journal of Immunologywas validated by qRT-PCR. To identify the gene targets of miR-132, we sought previously validated targets in literature, as well as predicted gene targets by miRWalk, an online software for miRNA target prediction that aggregates miRNA target predictions from 10 computational algorithms (DIANAmT, miRanda, miRDB, miRWalk, RNAhybrid, PICTAR4, PICTAR5, PITA, RNA22, and Targetscan). Among the putative target genes of interest was transcriptional coactivator p300, previously identified as an miR-132 target in endothelial and monocytic models of viral infection (5), and predicted by 9 of 10 algorithms as a target of miR-132 based on sequence. In addition, miR-26a, another miRNA significantly upregulated at 72 h after M. tuberculosis infection, was also predicted to target p300 by 7 of 10 algorithms, although no such biological evidence yet exists in the literature. Therefore, there is solid support for some of these differentially regulated miRNAs to have a functional role during M. tuberculosis infection by targeting p300, a component of an important macrophage immune response pathway.
Changes in p300 protein levels correlate with alterations in miR-132 and miR-26a expression
To establish p300 as a target of miR-132 and miR-26a in human macrophages, we used transient knockdown or overexpression of these two miRNAs by transfection of miR-132-and miR-26a-specific inhibitors or mimics and assayed for p300 protein levels by Western blot analysis of transfected total cell lysates. Confirmation of miR-132 and miR-26a knockdown and overexpression by qRT-PCR demonstrated significant decrease (Fig. 3A, 3B) or increase (Fig. 3C, 3D ) of miRNA expression when compared with the appropriate transfection control. Knockdown of miR-132 and miR-26a in MDMs by miRNA inhibitors resulted in an increase in p300 protein levels when compared with the inhibitor negative control (Fig. 3E) . Conversely, overexpression of miR-132 and miR-26a by miRNA mimics led to reduced p300 protein levels when compared with the corresponding mimic negative control (Fig. 3F) . Individual knockdown or overexpression of miR-132 or miR-26a alone also produced similar results on p300 levels, but the effects were not as pronounced as the combined knockdown or overexpressing findings (Supplemental Fig. 2 ). Based on these data, we conclude that p300 is also a target of miR-132 in human macrophages; further, we demonstrate the novel finding that miR26a also targets p300.
miR-132 and miR-26a target p300 by directly binding to the p300 39UTR
To demonstrate that miR-132 and miR-26a directly regulate p300 protein levels by targeting p300 mRNA, we cloned the p300 39UTR fragment containing the binding sites for both miR-132 and miR26a into a luciferase reporter plasmid (pGL3_CMV) downstream of the luciferase gene. Using HEK293 cells for the target validation assays, we cotransfected the reporter plasmid containing the p300 39UTR fragment along with either miR-132 or miR-26a mimic alone, both mimics combined, or scrambled control by Lipofectamine 2000, and after 48 h we assessed luciferase activity. Our results showed a significant decrease in light production with addition of both miR-132 and miR-26a mimics as compared with the scrambled control (Fig. 4) . The combined effect of both miR-132 and miR-26a on quenching luciferase activity was stronger than addition of the individual miRNAs. To further demonstrate the specificity of miR-132 and miR-26a for the p300 39UTR, we mutated four nucleotides in the seed sequence of the 39UTR binding site for each miRNA (indicated in bold). Luciferase expression from the plasmids with mutated p300 39UTR seed sequences remained at similar levels after cotransfection with both miR-132 and miR-26a mimics, and transfection with the scrambled control. These data provide evidence that miR-132 and miR26a alter p300 protein levels by directly targeting p300 mRNA through binding sites in the p300 39UTR.
miR-132 and miR-26a regulate transcriptional and translational macrophage responses to IFN-g
Because p300 is an important transcriptional mediator of IFN-g responses, we hypothesized that knockdown of miR-132 and miR26a could improve IFN-g responses in human macrophages via increased p300 levels. We assessed the expression of six known IFN-g-responsive genes encompassing a variety of macrophage functions, including FcgRI/CD64, CYBB, IRF1, HLA-DRa, CXCL10, and B.7.2/CD86, by qRT-PCR in miR-132 and miR-26a knockdown MDMs (24-h transfection) after treatment with rIFN-g for 6 h or 24 h. Our results demonstrate increased transcriptional expression of all six genes upon IFN-g stimulation in miR-132 and miR-26a knockdown cells when compared with the transfection control cells (also treated with IFN-g; Fig. 5A-F) . In addition to increased mRNA levels, we observed increased cellsurface protein expression of FcgRI/CD64 (Fig. 5G ) and HLA-DR (Fig. 5H ) in knockdown MDMs by confocal microscopy at 48 h after IFN-g treatment, indicating that there was also increased translational expression. Western blot analysis of FcgRI and HLA-DR expression in MDMs after miR-132 and miR-26a knockdown without IFN-g stimulation demonstrated no change in FcgRI expression and a small but significant increase in HLA-DR (data not shown). Therefore, we demonstrate that knockdown of miR-132 and miR-26a in human macrophages can improve tran-FIGURE 4. miR-132 and miR-26a directly target the p300 39UTR. Luciferase reporter plasmids were constructed with either the wild-type p300 39UTR segment containing the miR-132 and miR-26a binding sites (p300 UTR) or the p300 39UTR with seed sequences mutated as indicated (p300 mut). Mutated sequences are indicated in bold. Luciferase activity of HEK293 cells transfected with either the p300 UTR or the p300 mut plasmid along with miR-132 and/or miR-26a mimics or scrambled control by Lipofectamine 2000 was determined. Luciferase activity was normalized to total protein in each group. Data shown are the mean 6 SD of three replicates of one representative experiment (n = 2). *p , 0.05. scriptional responses to IFN-g (via increased expression of p300), and these increased mRNA levels correspond to increases in protein expression of IFN-g-induced genes.
To demonstrate that the previously observed increases in transcriptional and translational responses to IFN-g are a result of miR-132 and miR-26a targeting of p300 and not off-target effects of these miRNAs on other IFN-g pathway proteins, we assessed effects of miR-132 and miR-26a knockdown on integral downstream IFN-g signaling proteins. Binding of IFN-g to its receptor results in recruitment of JAK1 and JAK2, which phosphorylates STAT1 leading to its homodimerization and translocation to the nucleus to associate with p300. Western blot analyses of STAT1, JAK1, and JAK2 (Fig. 6A-C) after miR-132 and miR-26a knockdown in MDMs show no significant changes in expression of these proteins relative to the negative control group, indicating that miR-132 and miR-26a do not affect expression of these IFN-g pathway proteins.
In addition, to further demonstrate that the increased transcriptional responses after miR-132 and miR-26a knockdown are mediated by increased p300 protein levels and not a result of widespread increases in transcription due to miRNA knockdown, we assessed transcriptional responses of IFN-g-induced JAK-STAT-independent genes. These genes include CCL3/MIP-1a, CCL4/MIP-1b, and CEBPb, which are known to be induced by IFN-g but whose signaling after IFN-g stimulation is not mediated through the JAK-STAT signaling pathway, and thus do not require association of STAT1 homodimers with p300 to initiate their transcription (26, 27) . After miR-132 and miR-26a knockdown in MDMs and treatment with IFN-g, transcriptional levels of CCL3/ FIGURE 5. miR-132 and miR-26a knockdown improves macrophage responses to IFN-g. miR-132 and miR-26a were knocked down in MDMs by transfection with miR-132 and miR-26a inhibitors, and then stimulated with 40 ng/ml recombinant human IFN-g. Cells were lysed at 6 or 24 h to assay for transcription of known IFN-g-responsive genes (A) CD64/FcgRI (n = 5), (B) CYBB/p91-PHOX (n = 5), (C) IRF-1 (n = 4), (D) HLA-DRa (n = 4), (E) CXCL10 (n = 3), and (F) CD86/B7.2 (n = 4) by qRT-PCR. Shown are cumulative data from multiple donors, normalized to b-actin, each performed in triplicate (mean 6 SEM). Transfected MDMs on coverslips were stimulated with IFN-g for 48 h and stained with Ab for FcgRI (G) or HLA-DR (H) and examined by confocal microscopy (original magnification 3400). Shown are representative sections from one of three independent experiments performed on triplicate coverslips. Mean fluorescence intensity was calculated from at least 10 cross-sectional images and normalized to the number of nuclei, then plotted as fold increase relative to the transfection control group (n = 3, mean 6 SEM). *p , 0.05, **p , 0.01, ***p , 0.001.
MIP-1a, CCL4/MIP-1b, and CEBPb were assessed by qRT-PCR. Transcription of CCL3/MIP-1a, CCL4/MIP-1b, and CEBPb was not significantly altered in the miR-132 and miR-26a knockdown MDMs compared with the control knockdown group, which also received IFN-g treatment (Fig. 6D-F) . Together, these data provide further support that the increased transcriptional responses to IFN-g previously observed are mediated through increased protein levels of p300, as a result of decreased miR-132 and miR-26a expression.
Knockdown of miR-132 and miR-26a improves IFN-gmediated macrophage function
Because we previously determined that modulation of miR-132 and miR-26a expression regulates macrophage transcriptional and translational responses to IFN-g, we next analyzed effects of these two miRNAs on IFN-g-regulated macrophage function. We assayed for function of the increased cell-surface FcgRI/CD64 levels by IgG-mediated phagocytosis of SRBCs. MDMs transfected with miR-132 and miR-26a inhibitors for 24 h and treated with IFN-g for 48 h were incubated with IgG-coated SRBCs. We found increased numbers of phagocytosed SRBCs in miR-132 and miR-26a knockdown MDMs compared with the transfection control MDMs (Fig. 7) . Thus, together our data provide evidence that suppression of miR-132 and miR-26a expression improves the IFN-g-induced activation and function of human macrophages, and suggests that activation of these two miRNAs by M. tuberculosis may be an effective pathogen survival mechanism.
Expression of HLA-DR and FcgRI are decreased during M. tuberculosis infection, correlating with increased miR-132 and miR-26a levels
To further support our hypothesis that increased expression of miR-132 and miR-26a after M. tuberculosis infection dampens mac-FIGURE 6. miR-132 and miR-26a knockdown do not alter other proteins in the IFN-g signaling pathway or JAK-STAT-independent genes. After knockdown of miR-132 and miR-26a by transfection with miRNA inhibitors, (A) STAT1, (B) JAK1, and (C) JAK2 protein levels were analyzed by Western blot of protein-matched whole-cell lysates (top panels). Blots were reprobed with actin as a loading control. Cumulative densitometry analyses of immunoblot results from three independent experiments show no significant changes in expression levels of these proteins with miR-132 and miR-26a knockdown (bottom panels). To assess expression of the IFN-g-induced JAK-STAT-independent genes (D) CCL3, (E) CCL4, and (F) CEBPb, miR-132 and miR-26a were knocked down in MDMs by transfection with miR-132 and miR-26a inhibitors and then stimulated with 40 ng/ml recombinant human IFN-g. Cells were lysed at 6 or 24 h to assay for transcription by qRT-PCR. Shown are cumulative data from two individual donors, normalized to b-actin, each performed in triplicate (mean 6 SEM).
rophage immune functions, we assayed for expression of FcgRI and HLA-DR in M. tuberculosis-infected MDMs by Western blot. We observed decreased expression of both FcgRI (Fig. 8A ) and HLA-DR (Fig. 8B ) 72 h postinfection as compared with the timematched noninfected lysates. These decreases in protein levels correlate with the increase in miR-132 and miR-26a expression observed during our initial screen of miRNAs altered during M. tuberculosis infection. When increased expression of miR-132 and miR-26a after M. tuberculosis infection was prevented by transfection of miR-132 and miR-26a inhibitors, we observed small but reproducible increases in FcgRI (Fig. 8C ) and HLA-DR (Fig. 8D ) expression as compared with the scrambled control at 72 h after M. tuberculosis infection. Together, our data indicate that increased host miRNA expression of miR-132 and miR-26a downregulate key macrophage host defense functions and provide another mechanism used by M. tuberculosis to ensure its survival.
Discussion
Recent years have witnessed a spate of investigation on the dysregulation and roles of miRNAs during bacterial infections (28), including M. tuberculosis (29) . However, with some exceptions (17, (30) (31) (32) (33) (34) (35) , the majority of these studies have failed to identify downstream effects on the host immune response for the miRNAs detected with altered expression. A major contributing factor to the lack of concrete targets is the use of mixed cell populations or sputum for the identification of differentially expressed miRNAs during M. tuberculosis infection. M. tuberculosis is an ancient organism that has coevolved with its human host; therefore, it is uniquely adapted for survival within its intracellular host: the macrophage (36) . To date, little data exist on how miRNAs alter human macrophage immune responses during infection, which are the first phagocyte immune responders to M. tuberculosis in the lung microenvironment (37) . This study emphasizes the effects of primary M. tuberculosis infection, which determines the outcome of active or latent infection, on macrophage miRNAs using a pure primary human macrophage model of tuberculosis. We have identified 31 miRNAs differentially expressed in primary human macrophages during infection with virulent M. tuberculosis and demonstrate an immune effect for two of these miRNAs: miR-132 and miR-26a.
By studying a pure population of human macrophages, we were able to pinpoint a direct effect of two miRNAs altered during M. tuberculosis infection on specific macrophage functions, which has broad implications for both M. tuberculosis and other macrophage-mediated diseases. Our data demonstrate that through a single miRNA, or multiple miRNAs acting in concert, an in-trinsic macrophage activation pathway can be tuned up or down, in this case, to the benefit of the invading pathogen. In identifying p300 as a target of upregulated miRNAs miR-132 and miR-26a during M. tuberculosis infection, we have uncovered another layer to the conundrum of IFN-g function against human tuberculosis. Building on the work of Ting et al. (9) that M. tuberculosis infection results in decreased association of p300 at g-activation sequence elements after IFN-g treatment, our work supports the role of miRNAs in mediating this effect, providing a mechanism for their observation. In total, this work supports the concept that M. tuberculosis modulates miR-132 and miR-26a, in addition to other host miRNAs, which can attenuate host immune responses to promote its own survival.
It stands to reason that miR-132 and miR-26a may normally function as negative regulators of macrophage activation by IFN-g. In the case of M. tuberculosis pulmonary infection, induction of these two miRNAs in alveolar macrophages serves to limit the immune response and damage to the delicate alveolar tissue space. However, whether the induction of miR-132 and miR-26a is initiated by M. tuberculosis or through internal host pathways was not addressed in this study and will be the focus of future work. In addition, whether this phenomenon is specific to virulent mycobacterial strains also requires further study. Regardless of whether it is the host or the pathogen that drives upregulation of miR-132 and miR-26a expression, we have assigned a novel role for miR-132 and miR-26a in human macrophages as regulators of the IFNg-induced macrophage activation pathway. This knowledge can lead the way to therapeutic regulation of macrophage activation via miRNAs for diseases of overt Th1-type IFN-g-mediated macrophage activation, or as adjunct therapy with IFN-g for treatment of tuberculosis. with miR-132 or miR-26a knockdown alone, while p300 protein levels decreased with miR-132 or miR-26a over-expression alone (right panels). Shown are representative data obtained from two independent experiments for each knock-down and over-expresser.
